Gene,Disease,OMIM phenotype MIM number,Disease severity,Regulatory element(s) impacted,Distance to promoter,Variant ID,ClinVar ID,ClinVar classification,PMID(s),Publication date,Coordinates (original build),hg build,Coordinates (hg38)
ANKI,Hereditary spherocytosis,182900,Moderate,"TATA-binding protein (TBP) and TFIID
complex binding element",In promoter,NM_000037.4(ANK1):c.-73_-72del,508,Pathogenic,16037067 (Gallagher et al. 2005),2005 Sep,,,
ARPC1B,Primary immune disorder,617718,Not specified,Not specified,In promoter,9 kb promoter deletion,N/A,N/A,32581362 (Turro et al. 2020),2020 Jul,,,
CHRNE,Congenital myasthenic syndrome,608931,Classical disease,N-box-binding element,In promoter,NM_000080.4(CHRNE):c.-11-85C>T,18353,Likely Pathogenic,10211467 (Nichols et al. 1999),1999 Apr,,,
CHRNE,Congenital myasthenic syndrome,608931,Classical disease,N-box-binding element,In promoter,NM_000080.3(CHRNE):c.-95G>A,465866,Pathogenic/Likely Pathogenic,11960891 (Abicht et al. 2002),2002 May,,,
CHRNE,Congenital myasthenic syndrome,608931,Classical disease,N-box-binding element,In promoter,NM_000080.3(CHRNE):c.-96G>A,N/A,N/A,10382905 (Ohno et al. 1999),1999 May,,,
GALT,Galactosemia,230400,Duarte variant,E-box-binding element,In promoter,NM_000155.2(GALT):c.-119_-116delGTCA,25111,Pathogenic/Likely Pathogenic;other,11286503 (Elsas et al. 2001),2001 Apr,,,
GJB1,Charcot-Marie-Tooth Neuropathy X,302800,Classical disease,Not specified,In promoter,NM_000166.6(GJB1):c.-103C>T,217166,Pathogenic,8757034 (Ionasescu et al. 1996),1996 Aug,,,
GJB1,Charcot-Marie-Tooth Neuropathy X,302800,Classical disease,SOX10-binding element,In promoter,NM_001097642.3(GJB1):c.-16-513,543921,Likely Pathogenic,15470753 (Houlden et al. 2004),2004 Nov,,,
GJBI,Charcot-Marie-Tooth Neuropathy X,302800,Classical disease,SOX10-binding element,In promoter,NM_001097642.3(GJB1):c.-16-513,10445,Pathogenic,8757034 (Ionasescu et al. 1996),1996 Aug,,,
GJB1,Charcot-Marie-Tooth Neuropathy X,302800,Classical disease,SOX10-binding element,In promoter,NM_001097642.3(GJB1):c.-16-511G>C,10449,Pathogenic,15470753 (Houlden et al. 2004),2004 Nov,,,
GJC2,Pelizaeus-Merzbacher-Like Disease,608804,Milder disease,SOX10-binding element,In promoter,NM_020435.3(GJC2):c.-167A>G,30759,Pathogenic,24374284 (Gotoh et al. 2014),2014 Mar,,,
GLIS3,"Diabetes mellitus, neonatal, with congenital hypothyroidism",610199,Milder disease,Not specified,In promoter,426 kb deletion encompassing part of the GLIS3 5' UTR,N/A,N/A,16715098 (Senée et al. 2006),2006 Jun,,,
GLIS3,"Diabetes mellitus, neonatal, with congenital hypothyroidism",610199,Milder disease,Not specified,In promoter,134 kb deletion encompassing part of the GLIS3 5' UTR,N/A,N/A,16715098 (Senée et al. 2006),2006 Jun,,,
GP1BB,Bernard-Soulier Syndrome,231200,Classical disease,GATA-binding element,In promoter,NR_037611.1(SEPT5-GP1BB):n.3581C>G,16041,Pathogenic,8703016 (Ludlow et al. 1996),1996 Sep,,,
HBB,Beta-thalassemia,613985,Beta-thalassemia intermedia,CACCC box,In promoter,NM_000518.5(HBB):c.-136C>T,36284,"Likely
pathogenic",11857738; 28385923 (Hardison et al. 2002; Ropero et al. 2017),2002 Mar; 2017 Oct,,,
HBB,Beta-thalassemia,613985,Beta-thalassemia intermedia,CACCC box,In promoter,NM_000518.5(HBB):c.-136C>G,15465,Pathogenic/Likely Pathogenic,11857738; 28385923 (Hardison et al. 2002; Ropero et al. 2017),2002 Mar; 2017 Oct,,,
HBB,Beta-thalassemia,613985,Beta-thalassemia intermedia,CACCC box,In promoter,NM_000518.5(HBB):c.-137C>0,15464,Pathogenic/Likely Pathogenic,11857738; 28385923 (Hardison et al. 2002; Ropero et al. 2017),2002 Mar; 2017 Oct,,,
HBB,Beta-thalassemia,613985,Beta-thalassemia intermedia,CACCC box,In promoter,NM_000518.5(HBB):c.-137C>A,36285,Pathogenic/Likely Pathogenic,11857738; 28385923 (Hardison et al. 2002; Ropero et al. 2017),2002 Mar; 2017 Oct,,,
HBB,Beta-thalassemia,613985,Beta-thalassemia intermedia,CACCC box,In promoter,NM_000518.5(HBB):c.-137C>T,36287,Pathogenic,11857738; 28385923 (Hardison et al. 2002; Ropero et al. 2017),2002 Mar; 2017 Oct,,,
HBB,Beta-thalassemia,613985,Beta-thalassemia intermedia,CACCC box,In promoter,NM_000518.5(HBB):c.-138C>A,393701,Pathogenic/Likely Pathogenic,11857738; 28385923 (Hardison et al. 2002; Ropero et al. 2017),2002 Mar; 2017 Oct,,,
HBB,Beta-thalassemia,613985,Beta-thalassemia intermedia,CACCC box,In promoter,NM_000518.5(HBB):c.-138C>T,15460,Pathogenic,11857738; 28385923 (Hardison et al. 2002; Ropero et al. 2017),2002 Mar; 2017 Oct,,,
HBB,Beta-thalassemia,613985,Beta-thalassemia intermedia,CACCC box,In promoter,NM_000518.5(HBB):c.-140C>T,15514,Pathogenic,11857738; 28385923 (Hardison et al. 2002; Ropero et al. 2017),2002 Mar; 2017 Oct,,,
HBB,Beta-thalassemia,613985,Beta-thalassemia intermedia,CACCC box,In promoter,NM_000518.5(HBB):c.-142C>T,15462,Pathogenic,11857738; 28385923 (Hardison et al. 2002; Ropero et al. 2017),2002 Mar; 2017 Oct,,,
HBB,Beta-thalassemia,613985,Beta-thalassemia intermedia,CACCC box,In promoter,NM_000518.5(HBB):c.-151C>T,15461,Pathogenic,11857738; 28385923 (Hardison et al. 2002; Ropero et al. 2017),2002 Mar; 2017 Oct,,,
HBB,Beta-thalassemia,613985,Beta-thalassemia intermedia,TATA box,In promoter,NM_000518.5(HBB):c.-78A>O,15470,Pathogenic,11857738; 28385923 (Hardison et al. 2002; Ropero et al. 2017),2002 Mar; 2017 Oct,,,
HBB,Beta-thalassemia,613985,Beta-thalassemia intermedia,TATA box,In promoter,NM_000518.5(HBB):c.-78A>G,15471,Pathogenic/Likely pathogenic,11857738; 28385923 (Hardison et al. 2002; Ropero et al. 2017),2002 Mar; 2017 Oct,,,
HBB,Beta-thalassemia,613985,Beta-thalassemia intermedia,TATA box,In promoter,NM_000518.5(HBB):c.-79A>C,869288,Pathogenic,11559932 (Sadiq et al. 2001),2001 Sep,,,
HBB,Beta-thalassemia,613985,Beta-thalassemia intermedia,TATA box,In promoter,NM_000518.5(HBB):c.-79A>G,15469,Pathogenic,11857738; 28385923 (Hardison et al. 2002; Ropero et al. 2017),2002 Mar; 2017 Oct,,,
HBB,Beta-thalassemia,613985,Beta-thalassemia intermedia,TATA box,In promoter,NM_000518.5(HBB):c.-80T>G,869289,Pathogenic,26635043 (Henderson et al. 2016),2015 Dec,,,
HBB,Beta-thalassemia,613985,Beta-thalassemia intermedia,TATA box,In promoter,NM_000518.5(HBB):c.-80T>C,869290,Pathogenic,11857738; 28385923 (Hardison et al. 2002; Ropero et al. 2017),2002 Mar; 2017 Oct,,,
HBB,Beta-thalassemia,613985,Beta-thalassemia intermedia,TATA box,In promoter,NM_000518.5(HBB):c.-80T>A,15467,Pathogenic,11857738; 28385923 (Hardison et al. 2002; Ropero et al. 2017),2002 Mar; 2017 Oct,,,
HBB,Beta-thalassemia,613985,Beta-thalassemia intermedia,TATA box,In promoter,NM_000518.5(HBB):c.-81A>G,15466,Pathogenic,11857738; 28385923 (Hardison et al. 2002; Ropero et al. 2017),2002 Mar; 2017 Oct,,,
HBB,Beta-thalassemia,613985,Beta-thalassemia intermedia,TATA box,In promoter,NM_000518.5(HBB):c.-82C>A,15492,Pathogenic,11857738; 28385923 (Hardison et al. 2002; Ropero et al. 2017),2002 Mar; 2017 Oct,,,
HBD,Delta-thalassemia,N/A,delta(+)-thalassemia,GATA1 binding element,In promoter,NM_000519.3(HBD):c.-126A>T,15085,Pathogenic,12402333 (DeAngioletti et al. 2002),2002 Nov,,,
HBD,Delta-thalassemia,N/A,delta(+)-thalassemia,GATA1 binding element,In promoter,NM_000519.3(HBD):c.-127T>C,15072,Pathogenic,1515647 (Matsuda et al. 1992),1992 Sep,,,
HBD,Delta-thalassemia,N/A,delta(+)-thalassemia,TATA box,In promoter,NM_000519.3(HBD):c.-81A>G,15087,Pathogenic,15921167 (Frischknecht and Dutly 2005),2004 Nov,,,
HCFC1,X-linked intellectual developmental disorder-3,309541,Classical disease,YY1-binding element,In promoter,NM_005334.3(HCFC1):c.-970T>C,39694,Pathogenic,23000143 (Huang et al. 2012),2012 Oct,,,
HNF1A,MODY3,600496,Not specified,Not specified,In promoter,NM_000545.8(HNF1A):c.-119del,14936,Pathogenic,10649494 (Godart et al. 2000),2000 Jan,,,
LDLR,Familial hypercholesterolemia,143890,Not specified,SP1-binding element,In promoter,NM_000527.4(LDLR):c.-138del,3745,Likely Pathogenic,14616764 (Dedoussis et al. 2003),2003 Nov,,,
MLH1,Lynch syndrome,609310,Classical disease,Not specified,In promoter,NM_000249.4(MLH1):c.-27C>A,89589,Pathogenic,21840485 (Hitchins et al. 2011),2011 Aug,,,
MPL,Thrombocytopenia,604498,Moderate,Not specified,In promoter,GRCh37:chr1:43803414G>A,N/A,N/A,32581362 (Turro et al. 2020),2020 Jul,,,
MSH2,Lynch syndrome,120435,Classical disease,E1A-F binding element,In promoter,NM_000251.2(MSH2):c.-78_-77del,90494,Likely Pathogenic,17894833 (Yan et al. 2007),2007 Dec,,,
NIPBL,Cornelia de Lange syndrome,122470,Mild form,Not specified,In promoter,NM_133433.4(NIPBL):c.-321_-320delinsA,2151,Pathogenic,16799922 (Borck et al. 2006),2006 Aug,,,
PIGY,Hyperphosphatasia with impaired intellectual development syndrome-6,616809,Milder disease,SP1-binding element,In promoter,NM_001042616.2(PIGY):c.-540G>A,222025,Pathogenic,26293662 (Ilkovski et al. 2015),2015 Nov,,,
PKLR,Pyruvate kinase deficiency,266200,Severe disease,GATA1 binding element,In promoter,NM_000298.6(PKLR):c-72A>G,N/A,N/A,11054094 (Manco et al. 2000),2000 Sep,,,
PKLR,Pyruvate kinase deficiency,266200,Severe disease,Not specified,In promoter,NM_000298.6(PKLR):c-83G>C,N/A,N/A,12393511 (Van Wijk et al. 2003),2003 Feb,,,
RB1,Hereditary retinoblastoma,180200,Unilateral retinoblastoma,ATF binding element,In promoter,NM_000321.2(RB1):c.-189G>T,13085,Pathogenic,1881452 (Sakai et al. 1991),1991 Sep,,,
RB1,Hereditary retinoblastoma,180200,Bilateral and unilateral retinoblastoma,SP1-binding element,In promoter,NM_000321.2(RB1):c.-198G>A,13086,Pathogenic,1881453 (Sakai et al. 1991),1991 Sep,,,
RBI,Hereditary retinoblastoma,180200,Not specified,SP1-binding element,In promoter,NM_000321.3(RB1):c.-206_-189del,995907,Likely Pathogenic,28873162 (Mandelker et al. 2017),2017 Sep,,,
RBM8A,"Radial aplasiathrombocytopenia syndrome (Thrombocytopenia Absent Radius Syndrome, TAR)",274000,Milder disease,Not specified,In promoter,NM_005105.5(RBM8A):c.-21G>A,30464,Pathogenic/Likely Pathogenic;other,22366785 (Albers et al. 2012),2012 Feb,,,
SH2D1A,X-linked lymphoproliferative disease,308240,Not specified,CCAAT box,In promoter,NM_002351.5(SH2D1A):c.-10C>T,10906,Pathogenic,9771704 (Coffey et al. 1998),1998 Oct,,,
SLC39A4,Acrodermatitis enteropathica,201100,Classical disease,CCAAT box,In promoter,NM_130849.4(SLC39A4):c.-169A > G,N/A,N/A,https://doi.org/10.1101/2022.09.09.22279746 (Galey et al. 2022),2022 Sep,,,
SPINKI,Juvenile onset chronic pancreatitis,167800,Not specified,Not specified,In promoter,IM_003122.5(SPINK1):c.-191-24G>A,13762,Pathogenic,11355022 (Kaneko et al. 2001),2001 Feb,,,
TXNL4A,Burn-McKeown syndrome,608572,Classical disease,Not specified,In promoter,NC_000018.9:g.77748581_77748614del34,162203,Conflicting interpretations of pathogenicity,25434003 (Wieczorek et al. 2014),2014 Dec,,,
TXNL4A,Burn-McKeown syndrome,608572,Classical disease,Not specified,In promoter,NC_000018.9(TXNL4A):g.77748604_77748637del34,190413,Pathogenic,25434003 (Wieczorek et al. 2014),2014 Dec,,,
UROS,Congenital erythropoietic porphyria (CEP),263700,Severe disease,GATA1 binding element,In promoter,NM_000375.3(UROS):c.-203T>C,3762,Pathogenic,11254675 (Solis et al. 2001),2001 Mar,,,
UROS,Congenital erythropoietic porphyria (CEP),263700,Mild disease,Not specified,In promoter,NM_000375.3(UROS):c.-26-183G>A,3763,Pathogenic,11254676 (Solis et al. 2001),2001 Mar,,,
UROS,Congenital erythropoietic porphyria (CEP),263700,Mild disease,Not specified,In promoter,NM_000375.3(UROS):c.-26-193C>A,3764,Pathogenic,11254677 (Solis et al. 2001),2001 Mar,,,
UROS,Congenital erythropoietic porphyria (CEP),263700,Severe disease,CP2-binding element,In promoter,NM_000375.3(UROS):c.-26-197C>A,3765,Pathogenic,11254678 (Solis et al. 2001),2001 Mar,,,
VHL,von Hippel-Lindau disease,193300,Not specified,Not specified,In promoter,NM_000551.3(VHL):c.-75_-55del,166561,Likely Pathogenic,22357542 (Wu et al. 2012),2012 Apr,,,
DLX5,Split hand split foot malformation (SHFM),183600,Reduced penetrance,Not specified,850 kb upstream,1 Mb deletion,N/A,N/A,26075025 (Delgado and Velinov 2015),2015 Jun,,,
DLX5,Split hand split foot malformation (SHFM),183600,Reduced penetrance,DYNC1I1 exonic enhancers,835 kb upstream,106 kb deletion,N/A,N/A,24459211 (Allen et al. 2014),2014 Apr,"chr7:95,704,809-chr7:95,810,746",hg19,
DLX5,Split hand split foot malformation (SHFM),183600,Not specified,DYNC1I1 exonic enhancers,370 kb upstream,t(2;7)(p25.1;q22) translocation,N/A,N/A,24459212 (Allen et al. 2014),2014 Apr,"chr7:96,229,309; chr2:10,585,833",hg19,
FOXC2,Lymphedema-distichiasis syndrome,153400,Not specified,Not specified,120 kb downstream,Translocation,N/A,N/A,11078474 (Fang et al. 2000),2000 Dec,"chr16:86,566,829-86,569,728",hg38,
FOXG1,"Rett syndrome, congenital variant",613454,Severe phenotype,Enhancer,265 kb downstream,Translocation,N/A,N/A,21441262 (Kortüm et al. 2011),2011 Jun,"chr14:28,766,787-28,770,277",hg38,
FOXL2,Blepharophimosis-ptosis-epicanthus-inversus syndrome,110100,Not specified,Not specified,180 kb upstream,Translocation,N/A,N/A,11175783 (Crisponi et al. 2001),2001 Feb,"chr3:138,944,224-138,947,137",hg38,
GATA2,MonoMAC syndrome,614172,Classical phenotype,Enhancer,9.5 kb downstream,28 bp deletion,N/A,N/A,23502222; 22996659 (Johnson et al. 2012; Hsu et al. 2013),2013 May; 2012 Oct,???,hg19,
GATA2,MonoMAC syndrome,614172,Classical phenotype,Enhancer,,"GRCh38.p7 chr3:128,604,048A>T",,,37595058 (West et al. 2023),2023 Oct,chr3:128604048; chr3:128322891,hg38; hg19,
GATA2,MonoMAC syndrome,614172,Classical phenotype,ETS binding element,9.5 kb downstream,NM_032638.5(GATA2):c.1017+572C>T,566562,Pathogenic/Likely Pathogenic,23502222; 20040766 (Vinh et al. 2010; Hsu et al. 2013),2013 May; 2010 Feb,,,
GLI3,Greig syndrome,175700,Classical phenotype,Not specified,10 kb downstream,Translocation,N/A,N/A,1650914 (Vortkamp et al. 1991),1991 Aug,,,
HBA,Alpha-thalassemia,604131,Not specified,Not specified,10 kb downstream,62 kb deletion,N/A,N/A,2364173 (Hatton et al. 1990),1990 Jul,,,
HBA,Alpha-thalassemia,604131,Not specified,HS-40 element,60 kb upstream,Multiple deletions,N/A,N/A,18391781 (Higgs and Wood 2008),2008 May,,,
HBB,Beta-thalassemia,613985,Milder disease,Not specified,50 kb upstream,Translocation,N/A,N/A,6318113 (Kioussis et al. 1983),1983 Dec,,,
IRF6,Van der Woude syndrome (VWS),119300,Classical phenotype,"Disruption of p63 and E47-binding element, and creation of Lef1 binding element",9.7 kb upstream,MCS9.7-350dupA,N/A,N/A,24442519 (Fakhouri et al. 2014),2014 May,,,
LRBA,Autoantibody-mediated pancytopenia,614700,Not specified,CTCF-binding element,53 kb downstream,7.7 kb deletion,N/A,N/A,32581362 (Turro et al. 2020),2020 Jul,,,
MAF,"Cataract, anterior segment dysgenesis and microphthalmia",610202,Severe phenotype (associated with unbalanced translocation),Not specified,1 Mb upstream,Translocation,N/A,N/A,11772997 (Jamieson et al. 2002),2002 Jan,,,
PAH,Phenylketonuria,261600,Not specified,Enhancer,407 bp upstream,NM_001354304.2(PAH):c.-95-4071_-95-313del; 3.7 kb deletion,638,Likely Pathogenic,11935335 (Chen et al. 2002),2002 Mar,??? (Not compatible with other databases),???,
PAX6,Aniridia,106210,Classical phenotype,Not specified,150 kb downstream,Translocation,N/A,N/A,7795596 (Fantes et al. 1995),1995 Mar,,,
PAX6,Aniridia,106210,Classical phenotype,PAX6 autoregulatory element,150 kb downstream,NM_019040.5(ELP4):c.1143+1476C>A,120328,Pathogenic,24290376 (Bhatia et al. 2013),2013 Dec,,,
PITX2,Axenfeld-Rieger syndrome,180500,Not specified,Not specified,10 kb upstream,7.6 Mb deletion,N/A,N/A,20881290 (Volkmann et al. 2011),2011 Mar,,,
PITX2,Axenfeld-Rieger syndrome,180500,Not specified,Not specified,18 kb upstream,Translocation,N/A,N/A,14991915 (Trembath et al. 2004),2004 Feb,,,
PITX2,Axenfeld-Rieger syndrome,180500,Not specified,Not specified,76 kb upstream,Translocation,N/A,N/A,14991916 (Trembath et al. 2004),2004 Feb,,,
PLP1,Spastic paraplegia type 2,312920,Milder disease,Not specified,136 kb downstream,150 kb duplication,N/A,N/A,16374829 (Lee et al. 2006),2006 Feb,,,
POU3F4,"X-linked deafness type 3
(DFN3)",304400,Classical phenotype,Not specified,900 kb downstream,Common 8 kb deletion,N/A,N/A,8872461 (De Kok et al. 1996),1996 Sep,,,
SERPINHI,Osteogenesis imperfecta (OI),613848,Moderate phenotype,Enhancer,2.37 kb upstream,"5,274 bp deletion",N/A,N/A,31179625 (Schwarze et al. 2019),2019 Aug,chr11: 75554407-75559680; chr11: 75265452-75270725,hg38; hg19,
SHH,Holoprosencephaly,142945,Unspecified,Not specified,265 kb upstream,"t(2,7)(q31;q36)",N/A,N/A,9254845 (Roessler et al. 1997),1997 Aug,,,
SHH,Holoprosencephaly,142945,Unspecified,SBE2 enhancer,460 kb upstream,C>T variant,N/A,N/A,18836447 (Jeong et al. 2008),2008 Nov,???,???,
SHH,Holoprosencephaly spectrum (HPES); severe upper limb syndactyly with lower limb synpolydactyly,142945,,Enhancer hijacking; Loss of intrinsic enhancer; Gain of new enhancer,,,,,21948517 (Lettice et al. 2011),2011 Sep,,,
SHOX,Leri-Weill dyschondrosteosis (LWD),127300,Classical phenotype,Not specified,205 kb downstream,common 29 kb deletion,N/A,N/A,16175500 (Benito-Sanz et al. 2005),2005 Oct,,,
SHOX,Leri-Weill dyschondrosteosis (LWD) and idiopathic short stature (ISS),"127300,
300582",Milder disease,Enhancer,160 kb downstream,NC_000024.9:g.730550_778092del; 47 kb deletion,66087,Pathogenic,"        
22791839 (Benito-Sanz et al. 2012a, b)",2012 Jul,chrX:780549-828093; chrY: 730549-778093; chrX: 730550-778092 (ClinVar),hg19,
SIX3,Holoprosencephaly,157170,Not specified,Not specified,10-200 kb upstream,Translocation,N/A,N/A,10369266 (Wallis et al. 1999),1999 Jun,,,
SOX9,"46,XY male-to-female sex reversal and acampomelic form of campomelic dysplasia",114290,Classical phenotype,Not specified,380 kb upstream,1.5 Mb deletion,N/A,N/A,15060123 (Pop et al. 2004),2004 Apr,,,
SOX9,Campomelic dysplasia,114290,Milder disease,Not specified,917-855 kb upstream,t(7;17)(p13;q24),N/A,N/A,23648064 (Fonseca et al. 2013),2013 May,,,
SOX9,Campomelic dysplasia,114290,Milder disease,Not specified,601-585 kb upstream,t(17;20)(q24.3;q11.2),N/A,N/A,23648065 (Fonseca et al. 2013),2013 May,,,
SOX9,Campomelic dysplasia,114290,Milder disease,Not specified,50 kb upstream,t(7;17)(q34;q25.1),N/A,N/A,23648064; 8348155; 8001137 (Tommerup et al. 1993; Wagner et al. 1994; Fonseca et al. 2013),2013 May; 1993 Jun; 1994 Dec,,,
SOX9,Campomelic dysplasia,114290,Milder disease,Not specified,74-88 kb upstream,t(12;17)(q21.32;q24.3-q25.1),N/A,N/A,"23648064; 7747782; 8789441 (Ninomiya et al. 1995, 1996; Fonseca et al. 2013)",2013 May; 1995 Mar; 1996 Jan,,,
SOX9,Campomelic dysplasia,114290,Not specified,Not specified,88 kb upstream,t(2;17)(q35;q23-q24),N/A,N/A,23648064; 7990924; 1583645 (Young et al. 1992; Foster et al. 1994; Fonseca et al. 2013),2013 May; 1994 Dec; 1992 Apr,,,
SOX9,Campomelic dysplasia,114290,Milder disease,Not specified,110-140 kb upstream,t(9;17),N/A,N/A,23648064; 9724758 (Wunderle et al. 1998; Fonseca et al. 2013),2013 May; 1998 Sep,,,
SOX9,Campomelic dysplasia,114290,Milder disease,Not specified,134-142 kb upstream,t(13;17)(q22;q25.1),N/A,N/A,23648064; 10364523; 8348155; 8566951 (Tommerup et al. 1993; Wirth et al. 1996; Pfeifer et al. 1999; Fonseca et al. 2013),2013 May; 1999 Jul; 1993 Jun; 1996 Feb,,,
SOX9,Campomelic dysplasia,114290,Milder disease,Not specified,173-179 kb upstream,t(1;17)(q42.13;q24.3-q25.1),N/A,N/A,23648064; 10364523; 8348155; 8566951 (Tommerup et al. 1993; Wirth et al. 1996; Pfeifer et al. 1999; Fonseca et al. 2013),2013 May; 1999 Jul; 1993 Jun; 1996 Feb,,,
SOX9,Campomelic dysplasia,114290,Not specified,Not specified,161 kb upstream,t(5;17)(q23.2;q24),N/A,N/A,23648064; 21890680 (Sobreira et al. 2011; Fonseca et al. 2013),2013 May; 2011 Oct,,,
SOX9,Campomelic dysplasia,114290,Milder disease,Not specified,212-224 kb upstream,t(6;17)(q14;q24),N/A,N/A,23648064; 10364523; 8566951 (Wirth et al. 1996; Pfeifer et al. 1999; Fonseca et al. 2013),2013 May; 1999 Jul; 1996 Feb,,,
SOX9,Campomelic dysplasia,114290,Milder disease,Not specified,228-229 kb upstream,t(10;17)(q24;q23),N/A,N/A,23648064; 10364523 (Pfeifer et al. 1999; Fonseca et al. 2013),2013 May; 1999 Jul,,,
SOX9,Campomelic dysplasia,114290,Milder disease,Not specified,288-319 kb upstream,t(5;17)(q13.3;q24.2),N/A,N/A,23648064; 10364523 (Pfeifer et al. 1999; Fonseca et al. 2013),2013 May; 1999 Jul,,,
SOX9,Campomelic dysplasia,114290,Milder disease,Not specified,70-350 kb upstream,inv(17)(q11.2;q24.3-q25.1),N/A,N/A,23648064; 7666392; 9724758 (Mansour et al. 1995; Wunderleet al. 1998; Fonseca et al. 2013),2013 May; 1995 Jun; 1998 Sep,,,
SOX9,Campomelic dysplasia,114290,Milder disease,Not specified,375 kb upstream,t(1;17) (q42.1;q24.3),N/A,N/A,23648064; 17204049 (Leipoldt et al. 2007; Fonseca et al. 2013),2013 May; 2007 Jan,,,
SOX9,Campomelic dysplasia,114290,Milder disease,Not specified,380-1869 kb upstream,del(17)(q24.3),N/A,N/A,23648064; 15060123 (Pop et al. 2004; Fonseca et al. 2013),2013 May; 2004 Apr,,,
SOX9,Campomelic dysplasia,114290,Milder disease,Not specified,517-1477 kb upstream,del(17)(q24.3),39777,Pathogenic,23648064; 19449405 (Lecointre et al. 2009; Fonseca et al. 2013),2013 May; 2009 Jun,,,
SOX9,Campomelic dysplasia,114290,Not specified,Not specified,500-4700 kb upstream,t(7;17)(q33;q24)del(17)(q24.2q24.3),N/A,N/A,23648064; 20453475 (Jakubiczka et al. 2010; Fonseca et al. 2013),2013 May; 2010 May,,,
SOX9,Campomelic dysplasia,114290,Milder disease,Not specified,789 kb upstream,t(Y;17)(q11.2;q24.3),N/A,N/A,23648064; 17204049 (Leipoldt et al. 2007; Fonseca et al. 2013),2013 May; 2007 Jan,,,
SOX9,Pierre Robin sequence (PRS) and campomelic dysplasia,"261800,
114290",Milder disease,Not specified,899 kb upstream,t(4;17)(q28.3;q24.3),N/A,N/A,23648064; 15726498 (Velagaleti et al. 2005; Fonseca et al. 2013),2013 May; 2005 Apr,,,
SOX9,Pierre Robin sequence (PRS) and campomelic dysplasia,"261800,
114290",Not specified,Not specified,932 kb upstream,t(13;17)(q22.1;q22.3),N/A,N/A,23648064; 15717285 (Hill-Harfe et al. 2005; Fonseca et al. 2013),2013 May; 2005 Apr,,,
SOX9,Campomelic dysplasia,114290,Milder disease,Not specified,900 kb upstream,t(17;22)(q25.1;p11.2),N/A,N/A,23648064; 10364523; 15717285 (Pfeifer et al. 1999; Hill-Harfe et al. 2005; Fonseca et al. 2013),2013 May; 1999 Jul; 2005 Apr,,,
SRY,"46,XY sex reversal",400044,Classical phenotype,Not specified,1.8 kb upstream,25 kb deletion,N/A,N/A,1438307 (McElreavy et al. 1992),1992 Nov,,,
TWISTI,Saethre-Chotzen syndrome,101400,Classical phenotype,Not specified,260 kb downstream,Inversions and translocation,N/A,N/A,14513358 (Cai et al. 2003),"2003 Dec
",,,
UNC13D,Familial hemophagocytic lymphohistiocytosis 3,608898,Unspecified,ELF1-binding element,< 1 kb downstream,NM_199242.3(UNC13D):c.118-308C>T,533095,Pathogenic/Likely pathogenic,21931115 (Meeths et al. 2011),2011 Nov,,,